Vulvovaginal pseudomycosis simplex
Conditions
Interventions
Experimental group:Clotrimazole vaginal tablets + and skin antipruritic lotion sitz baths
Placebo group:Clotrimazole vaginal tablets + and skin antipruritic lotion placebo sitz baths
Sponsors
Guangdong Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Female patients aged 18 to 50 years; (2) Meet diagnostic criteria for simple vulvovaginal pseudomycosis; (3) Have a history of sexual intercourse; (4) Not planning pregnancy during the treatment and follow-up period; (5) agree to participate in the trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Combined with other diseases such as diabetes mellitus acquired immunodeficiency syndrome and other diseases that tend to cause vaginal microecological disorders; (2) Those with serious underlying diseases such as cardiovascular hepatic renal and hematopoietic systems or mental illnesses; (3) People with bacterial vaginosis trichomoniasis or other serious mixed infections; (4) Those who are allergic to the study drug; (5) Patients during pregnancy and lactation. (6) Patients who are participating in other clinical trials and undergoing treatment for vulvovaginal pseudomycosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal microecology testing; | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin Quality of Life Index;Skin Quality of Life Index;VVC Rating; | — |
Countries
China
Contacts
Public ContactDongfang Xiang
Guangdong Hospital of Traditional Chinese Medicine
Outcome results
None listed